Sorry, you need to enable JavaScript to visit this website.

Pfizer supports the global healthcare community’s independent initiatives (e.g., research, quality improvement or education) to improve patient outcomes in areas of unmet medical need that are aligned with Pfizer’s medical and/or scientific strategies.

Pfizer’s competitive grant program involves a publicly posted Request for Proposal (RFP) that provides detail regarding a specific area of interest and sets timelines for review and approval. Organizations are invited to submit an application addressing the specific gaps in research, practice or care as outlined in the specific RFP. The grant requester (and ultimately the grantee) is responsible for the design, implementation, sponsorship, and conduct of the independent initiative supported by the grant, including compliance with any regulatory requirements.

Sign-up to receive all GMG announcements, including Request for Proposal (RFP) postings.

Sign Up for Alerts
Title
Grant Type
Focus Area
Country
Application Due Date
BCMA-Directed Bispecific Antibody Treatment in Multiple Myeloma
Release Date:
Review Process: Pfizer Internal
Translation: Japanese (link)
Education Oncology Japan
Research on MBL producing Enterobacterales and/or Stenotrophomonas maltophilia
Release Date:
Review Process: Pfizer Internal
Research Hospital Austria, Brazil, China, France, Germany, Greece, India, Italy, Mexico, Saudi Arabia, Spain, Taiwan, Turkey, United Kingdom
Increase Awareness & Understanding of Emerging Hemophilia Treatment Options (Global excluding United States)
Release Date:
Review Process: Pfizer Internal
Education Rare Disease All
Optimal management of patients with prostate cancer receiving androgen deprivation therapy (ADT)
Release Date:
Partner: Sumitomo Pharma
Review Process: Pfizer Internal
Education Oncology USA
Title
Grant Type
Focus Area
Country
Application Due Date
Optimizing Telehealth Use in Canada
Release Date:
Review Process: Pfizer Internal
Translation: French (link)
Quality Improvement Internal Medicine Canada
Improving ATTR Amyloidosis Management in Spain
Release Date:
Review Process: Pfizer Internal
Quality Improvement Rare Disease Spain
Equity in Access to Rare Disease Clinical Trials
Release Date:
Review Process: Pfizer Internal
Quality Improvement Rare Disease USA
Management of Endometriosis
Release Date:
Partner: Myovant Sciences
Review Process: Pfizer Internal
Education Internal Medicine USA
2022 Inflammatory Bowel Disease (IBD) Fellowship
Release Date:
Review Process: Expert Review Panel
Fellowship Inflammation & Immunology USA
2022 IBD Competitive Grant Program
Release Date:
Review Process: Expert Review Panel
Research Inflammation & Immunology USA
Establishment of an Appropriate Network of Medical Care and Education for Axial Spondyloarthritis
Release Date:
Partner: The Japan Spondyloarthritis Society
Review Process: Expert Review Panel
Quality Improvement Inflammation & Immunology Japan
2022 Hemophilia ASPIRE-Africa Middle East, Asia-Pacific, & Latin America
Release Date:
Review Process: Expert Review Panel
Research Rare Disease All
2022 Global Hemophilia ASPIRE
Release Date:
Review Process: Expert Review Panel
Research Rare Disease All
Management of Uterine Fibroids and Endometriosis
Release Date:
Partner: Myovant Sciences
Review Process: Pfizer Internal
Education Internal Medicine USA
2022 Fellowship for Inflammatory Dermatological Diseases
Release Date:
Review Process: Expert Review Panel
Fellowship Inflammation & Immunology USA
2022 Rheumatology Fellowship
Release Date:
Review Process: Expert Review Panel
Fellowship Inflammation & Immunology USA